A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer

NCT06530797 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Interventions

DRUG: First-line Adebrelimab regiment for advanced stage ES-SCLC
DRUG: Second-line and beyond Adebrelimab regiment for advanced stage ES-SCLC

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China